Open Monoclonal Technology
	Developer of human monoclonal antibody platforms. The company develops human therapeutic antibodies based on transgenic rats for pharmaceutical companies.
	['', 'human monoclonal', ' ', 'antibody platform', ' ', 'transgenic rat', '']
Chromos Molecular Systems
	Developer of artificial chromosome technology for use in biopharmaceutical production. The company focuses on the development of proprietary artiﬁcial chromosome expression system technology that is used to engineer production quality cell lines to manufacture biopharmaceutical products, including monoclonal antibodies and the development of human therapeutic products.
	['', 'artificial chromosome technology', ' cell ', 'biopharmaceutical products', '']
Merrimack Pharmaceuticals
	Provider of commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The company develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis and MM-121, a human monoclonal antibody and therapeutic to block signaling of the ErbB3 receptor.
	['', 'commercial medicine', ' ', 'diagnostic treatment', ' cancer']
Domantis
	Developer of antibody molecules for therapy. It offers dual targeting human domain antibodies, which are used against cytokine targets for inflammatory diseases, tumour antigens present on the same tumour cells, and tumour growth/angiogenic factors for solid tumours; human domain antibodies with tailored serum half-life that are customized to achieve the desired therapeutic effect; human domain antibodies for diverse therapeutic targets, which are suited to inhibit receptor targets; and injectable and non-injectable human domain antibodies that treat diseases of the lung, as well as disorders of the gastro-intestinal tract.
	['', 'antibody therapeutic', ' ', 'domain antibody', ' ', 'antibody molecules', ' ', 'antibody molecules for therapy', ' ', 'dual targeting human domain antibodies', ' ', 'human domain antibodies', ' ', 'disease therapy', ' ', 'tumor therapy', ' ', 'disease therapy', '']
IQ Therapeutics
	Developer of human antibodies for the prevention and treatment of infectious diseases. The company provides research and development services and also offers technology as a service for third parties.
	['', 'human antibodies', ' ', 'infectious diseases', ' ', 'anthrax infections', '']
Immunologix
	Developer of antibody-based therapeutics. The company provides methods for producing human monoclonal antibodies against any target including bacterial and viral antigens, as well as tumor antigens, and human autoantigens. Its technology allows for the conversion of naïve B-cells (from a tonsillectomy or whole blood collection) to fully mature human B-cells producing the human antibody of interest.
	['', 'antibody therapeutic', ' ', 'human monoclonal', ' ', 'therapeutic device', '']
ESBATech
	Developer of human antibody fragments for therapeutic applications. The company also provides drug development and development programs.
	['', 'therapeutic application', ' ', 'antibody fragment', ' ', 'drug development', '']
